Urinary transforming growth factor beta-1 as a marker of renal dysfunction in sickle cell disease

Pediatric Nephrology

Volumn 26, Issue 2, 2011, Pages 275-280

  Mohtat, Davoud ^a   Thomas, Rosemary ^a   Du, Zangfang ^a   Boakye, Yaa ^a   Moulton, Thomas ^b   Driscoll, Catherine ^a   Woroniecki, Robert ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b BRONX LEBANON HOSPITAL CENTER   (United States)

Author keywords

Biomarkers; Fibrosis progression; Sickle cell nephropathy

Indexed keywords

BIOLOGICAL MARKER; HYDROXYUREA; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; TRANSFORMING GROWTH FACTOR BETA1;

ADOLESCENT; ADULT; ARTICLE; CHILD; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ACTIVITY; FEMALE; GLOMERULUS FILTRATION RATE; HEMOGLOBIN SC DISEASE; HEMOGLOBIN SD DISEASE; HUMAN; KIDNEY DYSFUNCTION; KIDNEY FIBROSIS; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SICKLE CELL ANEMIA; URINALYSIS; URINARY EXCRETION; URINE LEVEL;

ACUTE-PHASE PROTEINS; ADOLESCENT; AGE FACTORS; ALBUMINURIA; ANEMIA, SICKLE CELL; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; FEMALE; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; LIPOCALINS; MALE; PROTO-ONCOGENE PROTEINS; TRANSFORMING GROWTH FACTOR BETA; YOUNG ADULT;

EID: 78751591610     PISSN: 0931041X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00467-010-1677-9     Document Type: Article

References (44)

1. A Guasch J Navarrete K Nass CF Zayas 2006 Glomerular involvement in adults with sickle cell hemoglobinopathies: prevalence and clinical correlates of progressive renal failure J Am Soc Nephrol 17 2228 2235 1:CAS:528: DC%2BD28XosFalt78%3D 10.1681/ASN.2002010084 16837635
2. DR Powars DD Elliott-Mills L Chan J Niland AL Hiti LM Opas C Johnson 1991 Chronic renal failure in sickle cell disease: risk factors, clinical course, and mortality Ann Intern Med 115 614 620 1:STN:280:DyaK3MzmvFWhtA%3D%3D 1892333
3. RJ Falk JC Jennette 1994 Sickle cell nephropathy Adv Nephrol Necker Hosp 23 133 147 1:STN:280:DyaK2c3gsFCmtQ%3D%3D 8154349
4. PT Pham PC Pham AH Wilkinson SQ Lew 2000 Renal abnormalities in sickle cell disease Kidney Int 57 1 8 1:STN:280:DC%2BD3c%2FoslWhsA%3D%3D 10.1046/j.1523-1755.2000.00806.x 10620181
5. AN Thomas C Pattison GR Serjeant 1982 Causes of death in sickle-cell disease in Jamaica Br Med J (Clin Res Ed) 285 633 635 1:STN:280: DyaL3s7ivVamsQ%3D%3D 10.1136/bmj.285.6342.633
6. OS Platt DJ Brambilla WF Rosse PF Milner O Castro MH Steinberg PP Klug 1994 Mortality in sickle cell disease. Life expectancy and risk factors for early death N Engl J Med 330 1639 1644 1:STN:280:DyaK2c3jt1aruw%3D%3D 10.1056/NEJM199406093302303 7993409
7. DE Wesson 2002 The initiation and progression of sickle cell nephropathy Kidney Int 61 2277 2286 10.1046/j.1523-1755.2002.00363.x 12028473
8. VR Dharnidharka S Dabbagh B Atiyeh P Simpson S Sarnaik 1998 Prevalence of microalbuminuria in children with sickle cell disease Pediatr Nephrol 12 475 478 1:STN:280:DyaK1cvhs12mtg%3D%3D 10.1007/s004670050491 9745872
9. PG McBurney CD Hanevold CM Hernandez JL Waller KM McKie 2002 Risk factors for microalbuminuria in children with sickle cell anemia J Pediatr Hematol Oncol 24 473 477 10.1097/00043426-200208000-00013 12218596
10. DR Wigfall RE Ware MR Burchinal TR Kinney JW Foreman 2000 Prevalence and clinical correlates of glomerulopathy in children with sickle cell disease J Pediatr 136 749 753 1:STN:280:DC%2BD3c3pvFSisg%3D%3D 10.1067/mpd.2000.105998 10839871
11. AA Bakir SC Hathiwala H Ainis DO Hryhorczuk HL Rhee PS Levy G Dunea 1987 Prognosis of the nephrotic syndrome in sickle glomerulopathy. A retrospective study Am J Nephrol 7 110 115 1:STN:280:DyaL2s3mslygsg%3D%3D 10.1159/000167444 3605231
12. O Marsenic KG Couloures JM Wiley 2008 Proteinuria in children with sickle cell disease Nephrol Dial Transplant 23 715 720 1:CAS:528:DC%2BD1cXhvVemtbg%3D 10.1093/ndt/gfm858 18065783
13. KJ Gordon GC Blobe 2008 Role of transforming growth factor-beta superfamily signaling pathways in human disease Biochim Biophys Acta 1782 197 228 1:CAS:528:DC%2BD1cXjs1Wms7o%3D 18313409
14. M Blumenberg S Gao K Dickman AP Grollman EP Bottinger J Zavadil 2007 Chromatin structure regulation in transforming growth factor-beta-directed epithelial-mesenchymal transition Cells Tissues Organs 185 162 174 1:CAS:528:DC%2BD2sXmvFSnu74%3D 10.1159/000101317 17587822
15. S Chen B Jim FN Ziyadeh 2003 Diabetic nephropathy and transforming growth factor-beta: transforming our view of glomerulosclerosis and fibrosis build-up Semin Nephrol 23 532 543 1:CAS:528:DC%2BD2cXisVWl 10.1053/S0270-9295(03)00132-3 14631561
16. SB Nicholas 2003 Advances in pathogenetic mechanisms of diabetic nephropathy Cell Mol Biol (Noisy-le-grand) 49 1319 1325 1:CAS:528: DC%2BD2cXhslSisbk%3D
17. G Wolf 2006 Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway Kidney Int 70 1914 1919 1:CAS:528:DC%2BD28Xht1Cls7nP 16985515
18. RJ Falk J Scheinman G Phillips E Orringer A Johnson JC Jennette 1992 Prevalence and pathologic features of sickle cell nephropathy and response to inhibition of angiotensin-converting enzyme N Engl J Med 326 910 915 1:STN:280:DyaK387nvVeiuw%3D%3D 10.1056/NEJM199204023261402 1542341
19. MH Steinberg 2009 Genetic etiologies for phenotypic diversity in sickle cell anemia ScientificWorldJournal 9 46 67 19151898
20. J Mishra Q Ma A Prada M Mitsnefes K Zahedi J Yang J Barasch P Devarajan 2003 Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury J Am Soc Nephrol 14 2534 2543 1:CAS:528:DC%2BD3sXnt1aht74%3D 10.1097/01.ASN.0000088027.54400.C6 14514731
21. J Mishra C Dent R Tarabishi MM Mitsnefes Q Ma C Kelly SM Ruff K Zahedi M Shao J Bean K Mori J Barasch P Devarajan 2005 Neutrophil gelatinase-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery Lancet 365 1231 1238 1:CAS:528:DC%2BD2MXjtlWjsLg%3D 10.1016/S0140-6736(05)74811- X 15811456
22. MM Mitsnefes TS Kathman J Mishra J Kartal PR Khoury TL Nickolas J Barasch P Devarajan 2007 Serum neutrophil gelatinase-associated lipocalin as a marker of renal function in children with chronic kidney disease Pediatr Nephrol 22 101 108 10.1007/s00467-006-0244-x 17072653
23. GJ Schwartz GB Haycock CM Edelmann Jr A Spitzer 1976 A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine Pediatrics 58 259 263 1:CAS:528:DyaE28XlsFKisr4%3D 951142
24. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents 2004 The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents Pediatrics 114 555 576 10.1542/peds.114.2.S2.555
25. Okamoto Y, Gotoh Y, Uemura O, Tanaka S, Ando T, Nishida M (2005) Age-dependent decrease in serum transforming growth factor (TGF)-beta 1 in healthy Japanese individuals; population study of serum TGF-beta 1 level in Japanese. Dis Markers 21:71-74
26. KT McKie CD Hanevold C Hernandez JL Waller L Ortiz KM McKie 2007 Prevalence, prevention, and treatment of microalbuminuria and proteinuria in children with sickle cell disease J Pediatr Hematol Oncol 29 140 144 1:CAS:528:DC%2BD2sXksFGqtLw%3D 10.1097/MPH.0b013e3180335081 17356390
27. O Alvarez G Lopez-Mitnik G Zilleruelo 2008 Short-term follow-up of patients with sickle cell disease and albuminuria Pediatr Blood Cancer 50 1236 1239 10.1002/pbc.21520 18293385
28. O Alvarez B Montane G Lopez J Wilkinson T Miller 2006 Early blood transfusions protect against microalbuminuria in children with sickle cell disease Pediatr Blood Cancer 47 71 76 10.1002/pbc.20645 16261557
29. CD Fitzhugh DR Wigfall RE Ware 2005 Enalapril and hydroxyurea therapy for children with sickle nephropathy Pediatr Blood Cancer 45 982 985 10.1002/pbc.20296 15704213
30. M Suthanthiran LM Gerber JE Schwartz VK Sharma M Medeiros R Marion TG Pickering P August 2009 Circulating transforming growth factor-beta1 levels and the risk for kidney disease in African Americans Kidney Int 76 72 80 1:CAS:528:DC%2BD1MXntlGhsbg%3D 10.1038/ki.2009.66 19279557
31. F Schmitt F Martinez G Brillet I Giatras G Choukroun R Girot D Bachir F Galacteros B Lacour JP Grunfeld 1998 Early glomerular dysfunction in patients with sickle cell anemia Am J Kidney Dis 32 208 214 1:STN:280: DyaK1cznt1ejug%3D%3D 10.1053/ajkd.1998.v32.pm9708603 9708603
32. L Yu WA Border I Anderson M McCourt Y Huang NA Noble 2004 Combining TGF-beta inhibition and angiotensin II blockade results in enhanced antifibrotic effect Kidney Int 66 1774 1784 1:CAS:528:DC%2BD2cXhtVCgs7vF 10.1111/j.1523-1755.2004.00901.x 15496148
33. Y Huang NA Noble J Zhang C Xu WA Border 2007 Renin-stimulated TGF-beta1 expression is regulated by a mitogen-activated protein kinase in mesangial cells Kidney Int 72 45 52 1:CAS:528:DC%2BD2sXntVCjtL0%3D 10.1038/sj.ki.5002243 17396111
34. Gaedeke J, Peters H, Noble NA, Border WA (2001) Angiotensin II, TGF-beta and renal fibrosis. Contrib Nephrol (135):153-160
35. EJ Lewis LG Hunsicker RP Bain RD Rohde 1993 The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group N Engl J Med 329 1456 1462 1:STN:280: DyaK2c%2FhvFKitQ%3D%3D 10.1056/NEJM199311113292004 8413456
36. BM Brenner ME Cooper D de Zeeuw WF Keane WE Mitch HH Parving G Remuzzi SM Snapinn Z Zhang S Shahinfar 2001 Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy N Engl J Med 345 861 869 1:CAS:528:DC%2BD3MXntlelsLk%3D 10.1056/NEJMoa011161 11565518
37. M Zeisberg J Hanai H Sugimoto T Mammoto D Charytan F Strutz R Kalluri 2003 BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury Nat Med 9 964 968 1:CAS:528: DC%2BD3sXkvFOjs7Y%3D 10.1038/nm888 12808448
38. L Deelman K Sharma 2009 Mechanisms of kidney fibrosis and the role of antifibrotic therapies Curr Opin Nephrol Hypertens 18 85 90 1:CAS:528: DC%2BD1cXhsV2rsL7J 10.1097/MNH.0b013e32831c50a1 19077695
39. E Voskaridou E Terpos S Michail E Hantzi A Anagnostopoulos A Margeli D Simirloglou D Loukopoulos I Papassotiriou 2006 Early markers of renal dysfunction in patients with sickle cell/beta-thalassemia Kidney Int 69 2037 2042 1:CAS:528:DC%2BD28XkvVyrsLk%3D 10.1038/sj.ki.5000248 16501491
40. L Foucan V Bourhis J Bangou L Merault M Etienne-Julan RL Salmi 1998 A randomized trial of captopril for microalbuminuria in normotensive adults with sickle cell anemia Am J Med 104 339 342 1:CAS:528:DyaK1cXjtVKms74%3D 10.1016/S0002-9343(98)00056-4 9576406
41. KI Ataga EP Orringer 2000 Renal abnormalities in sickle cell disease Am J Hematol 63 205 211 1:CAS:528:DC%2BD3cXisVClsLg%3D 10.1002/(SICI)1096- 8652(200004)63:4<205::AID-AJH8>3.0.CO;2-8 10706765
42. A Guasch M Cua WE Mitch 1996 Early detection and the course of glomerular injury in patients with sickle cell anemia Kidney Int 49 786 791 1:STN:280:DyaK283jtFaltg%3D%3D 10.1038/ki.1996.109 8648921
43. O Alvarez G Zilleruelo D Wright B Montane G Lopez-Mitnik 2006 Serum cystatin C levels in children with sickle cell disease Pediatr Nephrol 21 533 537 10.1007/s00467-006-0033-6 16491413
44. R Marouf O Mojiminiyi N Abdella M Kortom H Al Wazzan 2006 Comparison of renal function markers in Kuwaiti patients with sickle cell disease J Clin Pathol 59 345 351 1:CAS:528:DC%2BD28XktVajs7g%3D 10.1136/jcp.2005.026799 16567469